Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 110, Issue 2, Pages 145-150
Publisher
Wiley
Online
2014-04-03
DOI
10.1002/jso.23612
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy
- (2012) Philippe E. Spiess et al. BJU INTERNATIONAL
- Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus
- (2012) Kwang Hyun Kim et al. BJU INTERNATIONAL
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular Diagnosis and Therapy of Kidney Cancer
- (2010) W. Marston Linehan et al. Annual Review of Medicine
- Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension
- (2010) Juan I. Martínez-Salamanca et al. EUROPEAN UROLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Contemporary Management of Renal Tumors With Venous Tumor Thrombus
- (2010) Frédéric Pouliot et al. JOURNAL OF UROLOGY
- The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
- (2010) Dalsan You et al. JOURNAL OF UROLOGY
- The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy
- (2010) Toni K. Choueiri et al. JOURNAL OF UROLOGY
- Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era
- (2009) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Treatment of Inferior Vena Cava Tumor Thrombus in Patients with Renal Cell Carcinoma
- (2009) Tae-Won Kwon et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Performance status and cytoreductive nephrectomy
- (2008) Brian Shuch et al. CANCER
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma
- (2008) Bernd Wagner et al. EUROPEAN UROLOGY
- Neoadjuvant Therapy with Sorafenib in Advanced Renal Cell Carcinoma with Vena Cava Extension Submitted to Radical Nephrectomy
- (2008) Franco Di Silverio et al. UROLOGIA INTERNATIONALIS
- Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi
- (2007) Pierre I. Karakiewicz et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More